IRIS
BATTAGLIA, GLORIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.674
AS - Asia 2.147
EU - Europa 1.048
SA - Sud America 396
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.395
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.608
SG - Singapore 886
CN - Cina 710
SE - Svezia 335
BR - Brasile 332
IE - Irlanda 323
HK - Hong Kong 174
TR - Turchia 162
VN - Vietnam 96
ZA - Sudafrica 78
NL - Olanda 76
DE - Germania 52
CA - Canada 42
FI - Finlandia 41
RU - Federazione Russa 40
FR - Francia 35
GB - Regno Unito 31
CI - Costa d'Avorio 30
AR - Argentina 27
IT - Italia 22
IN - India 21
UA - Ucraina 21
AT - Austria 19
BD - Bangladesh 17
MX - Messico 15
IQ - Iraq 12
JP - Giappone 12
ES - Italia 10
PL - Polonia 10
BE - Belgio 9
EC - Ecuador 9
MA - Marocco 8
AE - Emirati Arabi Uniti 7
VE - Venezuela 7
CL - Cile 6
CO - Colombia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
HR - Croazia 4
ID - Indonesia 4
IL - Israele 4
UZ - Uzbekistan 4
BO - Bolivia 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
AL - Albania 2
AU - Australia 2
EU - Europa 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
QA - Qatar 1
RS - Serbia 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 6.395
Salva come PNG Salva come JPEG
Città #
Chandler 524
Singapore 404
Dublin 323
Ashburn 315
Santa Clara 300
Hong Kong 172
Beijing 155
Dallas 137
Dearborn 130
Izmir 127
Nanjing 111
Johannesburg 74
Boardman 71
New York 70
Princeton 70
Los Angeles 58
Shanghai 50
Ho Chi Minh City 43
Wilmington 41
Columbus 40
Moscow 35
Helsinki 32
Hebei 30
Nanchang 29
Abidjan 27
Shenyang 27
São Paulo 27
Kocaeli 26
Buffalo 24
Toronto 22
Munich 21
Changsha 20
The Dalles 20
Hangzhou 19
Hanoi 19
Kunming 19
Guangzhou 18
Tianjin 18
Jiaxing 17
Vienna 17
Seattle 16
Hefei 14
Jinan 13
Belo Horizonte 12
Jacksonville 12
San Mateo 12
Tokyo 12
Zhengzhou 12
Montreal 11
Rio de Janeiro 11
Frankfurt am Main 10
Fremont 10
London 10
Norwalk 10
Brussels 9
Council Bluffs 9
Turku 9
Chicago 8
San Francisco 8
Stockholm 8
Houston 7
Porto Alegre 7
Warsaw 7
Ann Arbor 6
Baghdad 6
Boston 6
Brooklyn 6
Campinas 6
Curitiba 6
Denver 6
Haiphong 6
Hải Dương 6
Milan 6
Poplar 6
Nuremberg 5
Orem 5
Rome 5
Salvador 5
Wuhan 5
Atlanta 4
Borås 4
Brasília 4
Cambridge 4
Chennai 4
Dhaka 4
Dubai 4
Lanzhou 4
Leawood 4
Ningbo 4
Roubaix 4
Tashkent 4
Washington 4
Zagreb 4
Araxá 3
Baku 3
Barra Mansa 3
Buenos Aires 3
Caxias do Sul 3
Contagem 3
Edinburgh 3
Totale 4.087
Salva come PNG Salva come JPEG
Nome #
Long-term treatment for gastric and duodenal ulcer 144
Clinical markers of slow healing and relapsing gastric ulcer 137
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 136
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 130
Individualized treatment of duodenal ulcer disease. A pilot study 129
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 128
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 128
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 126
Gastric and duodenal ulcer in the same patient 125
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 125
[Clinical usefulness of the blood gastrin curve after protein meal in duodenal ulcer] 124
H2-blockers in the treatment of ulcer disease in the elderly 122
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 119
Compliance with therapy for ulcer disease: clinical experience and review of the literature 117
800 mg of cimetidine versus 300 mg of ranitidine at bedtime in the short-term treatment of duodenal ulcer: A cost/benefit study 117
Azithromycin for the cure of Helicobacter pylori infection 117
CARATTERISTICHE EPIDEMIOLOGICHE, CLINICHE E FUNZIONALI IN PAZIENTI CON SANGUINAMENTO DA ULCERA DUODENALE 116
Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study 114
Cefixime for the eradication of helicobacter pylori 110
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 109
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 106
Mucosal pepsin and group I pepsinogen concentration in peptic ulcer patients with a history of bleeding 105
Clarithromycin for the cure of Helicobacter pylori infection: One or two weeks of treatment 104
TERAPIA DI MANTENIMENTO PER UN ANNO CON ANTI-H2 NELL'ULCERA PEPTICA DELL'ANZIANO: IMPORTANZA DELLA SINTOMATOLOGIA COME MARKER DI RECIDIVA 104
A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study 103
Milk consumption and duodenal ulcer outcome: A short- and long-term study 102
Early drop in anti Helicobacter pylori IgG titre after eradication therapy with clarithromycin 102
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 100
A preliminary report on Helicobacter pylori and antral gastrin concentration in patients with duodenal ulcer 100
LA BULBODUODENITE NON ULCEROSA: ASPETTI CLINICI E TRATTAMENTO FARMACOLOGICO 99
Fasting and post-prandial serum gastrin concentrations in peptic ulcer disease. Pathophysiological considerations in relationship to the different localization 99
Blood pepsinogen as a subclinical marker for duodenal ulcer 98
A therapeutic strategy after a first ineffective cure of H. pylori infection. One-centre experience on 74 consecutive patients 98
H2antagonists and gastric ulcer: A multicenter, randomized, double-blind, controlled study comparing nizatidine with ranitidine 97
Gastric bicarbonate secretion in high-relapsing, smoking duodenal ulcer patients 97
ACIDO N-ACETILNEURAMINICO DOPO PENTAGASTRINA E SECRETINA IN SOGGETTI CON ULCERA DUODENALE E DISPEPSIA NON ULCEROSA 97
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 94
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 93
Gastric ulcer and stomach aging: Pathophysiology and clinical implications 91
Studio scintigrafico del tempo di svuotamento gastrico in pazienti con ulcera duodenale 90
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study 86
Personality traits and gastric acid secretion in ulcer disease 84
Ulcera gastrica, ulcera duodenale e gruppi sanguigni "maggiori e minori". Aspetti epidemiologici, correlazioni funzionali, implicazioni cliniche 83
Risk factors of duodenal ulcer bleeding: the role of smoking and nicotine 81
The natural history of duodenal ulcer disease 80
EFFETTO DELLA NIZATIDINA E DEL MISOPROSTOL SULL'ATTIVITA PEPTICA E SUL MUCO GASTRICO SOLUTO 77
ULCERA PEPTICA E CIRROSI EPATICA. CONSIDERAZIONI CLINICO-EPIDEMIOLOGISCHE 75
Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series 74
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study 73
Sucralfate gel versus ranitidine in the treatment of gastroesophageal reflux disease: A controlled study 71
Helicobacter pylori infection, cigarette smoking and alcohol consumption. A histological and clinical study on 286 subjects 70
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study 68
Ranitidine bismuthate citrate as a second step for the eradication of Helicobacter pylori 68
Serum pepsinogen A and C levels: A follow-up study on 476 patients after Helicobacter pylori eradication 67
Early fall of anti Helicobacter pylori IgG in eradicated patients with non-ulcer dyspepsia 67
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 67
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules 65
Valutazione clinica della gastrinemia basale nella malattia ulcerosa 65
Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs 65
Helicobacter pylori eradication: Can a successful therapy be predicted? 65
Sucralfate for preventing gastric ulcer relapse: A controlled prospective study 65
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 63
Hemorrhagic duodenal ulcer disease: Clinical and biochemical findings in a case-control pilot study 62
High IgE serum levels and "peptic" ulcers: clinical and functional approach 61
Lymphoid follicles in gastric mucosa of Helicobacter pylori infected patients regress after eradication treatment 58
Sucralfate and cisapride in the treatment of duodenogastric reflux and dyspepsia: A randomized study 58
One year follow-up of malt lymphoma of the stomach: Evidence for the need of an accurate diagnostic management 55
Helicobacter pylori and Serum Pepsinogen A, Pepsinogen C, and Gastrin: A Methodological Note 55
Seasonal Fluctuations in Peptic Ulcer Bleeding: An Italian Experience 48
LA TERAPIA DELLA MALATTIA ULCEROSA NELL'ANZIANO: STUDIO PROSPETTICO RANDOMIZZATO CON FARMACI ANTISECRETORI 43
Totale 6.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.749
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 5 1 15 29 10 7
2021/2022269 0 0 1 17 14 2 3 25 18 15 28 146
2022/20231.461 133 149 131 132 95 184 7 122 415 6 71 16
2023/2024402 13 49 11 9 31 127 7 34 17 34 33 37
2024/20251.742 36 78 90 100 284 284 92 71 200 115 112 280
2025/20261.609 303 250 333 222 456 45 0 0 0 0 0 0
Totale 6.471